Lipella Pharma enters $2.64M ATM equity facility with H.C. Wainwright

LIPELLA PHARMACEUTICALS INC.

ATM agreement for up to $2,641,881 of common stock at market prices.
H.C. Wainwright receives 3.0% cash commission on gross proceeds.
Proceeds will be used for working capital and general corporate purposes.
Shares offered under existing effective S-3 shelf registration.
No obligation to sell; company may suspend or terminate at any time.

item 1.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001753926-25-000585
form_type: 8-K
ticker: LIPO
cik: 0001347242
company_name: LIPELLA PHARMACEUTICALS INC.
filed_at: 2025-04-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:48.040854+00:00
generated_at: 2026-05-23T19:31:53.975921+00:00
sec_items: ["1.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001753926-25-000585
json_url: https://secwatch.observer/filing/0001753926-25-000585.json
markdown_url: https://secwatch.observer/filing/0001753926-25-000585.md
text_url: https://secwatch.observer/filing/0001753926-25-000585.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000585/0001753926-25-000585-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000585/g084763_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001753926-25-000585

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.